ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,793, issued on Sept. 16, was assigned to TMEM16A Ltd. (Welwyn Garden City, Great Britain).
"Modulators of TMEM16A for treating respiratory disease" was invented by Stephen Collingwood (Brighton, Great Britain), Jonathan David Hargrave (Abingdon, Great Britain), Duncan Alexander Hay (Abingdon, Great Britain) and Edward Walker (Abingdon, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of general formula (I):wherein R1, R2, R3, R4, A, Z1, Z2 and Y are as defined herein are useful for treating respiratory disease and other diseases and conditions modulated by TMEM16A."
The patent was filed on Dec. 10, 2021, under Application No....